Skip to main content

Table 3 The effects of age groups, gender, ADHD subtypes and methylphenidate (MPH) treatment on each index of TOVA

From: Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status

 

Omission errors

Commission errors

Response time

Response time variability

Response sensitivity (d’)

ADHD score

Age (<9 years vs. ≥9 years)

−0.30 (0.764)

0.51 (0.610)

2.34 (0.020)*

2.51 (0.013)*

2.57 (0.011)*

2.77 (0.006)**

Gender (female vs. male)

−0.18 (0.858)

0.91 (0.365)

0.44 (0.658)

0.96 (0.336)

0.50 (0.621)

−0.10 (0.924)

ADHD subtypes a

0.17 (0.862)

1.19 (0.234)

0.79 (0.432)

1.50 (0.136)

1.62 (0.107)

2.21 (0.029)*

MPH treatment

−0.14 (0.890)

2.02 (0.044)*

1.57 (0.119)

1.16 (0.247)

2.24 (0.026)*

1.42 (0.158)

Age × MPH treatment

−0.16 (0.870)

0.58 (0.561)

−2.72 (0.007)**

−1.24 (0.218)

−0.76 (0.446)

−1.61 (0.110)

Gender × MPH treatment

−2.30 (0.022)*

−1.39 (0.166)

0.51 (0.611)

−0.76 (0.447)

−2.41 (0.017)*

−0.04 (0.971)

ADHD subtypes × MPH treatment

0.91 (0.363)

−0.14 (0.886)

−0.33 (0.741)

−0.07 (0.943)

−0.01 (0.990)

−0.99 (0.322)

  1. Note: Data are expressed as statistical values, t (p-value), using linear mixed model analysis; a ADHD subtypes: inattentive type vs. hyperactive-impulsive type and combined type; *p<0.05, **p<0.01.
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us